Detalhe da pesquisa
1.
Factors associated with the misdiagnosis of neuromyelitis optica spectrum disorder.
Mult Scler Relat Disord
; 70: 104498, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36610360
2.
High-efficacy therapies reduce clinical and radiological events more effectively than traditional treatments in neuromyelitis optica spectrum disorder.
J Neurol
; 270(7): 3595-3602, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052668
3.
Treatment transitions in neuromyelitis optica spectrum disorder increase risk for disease advancement.
Mult Scler Relat Disord
; 79: 105041, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804767
4.
Hiding in plain sight: The magnitude of unused disease modifying therapies in multiple sclerosis and strategies for reducing the economic burden of care.
Mult Scler Relat Disord
; 63: 103920, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35661567
5.
Dorsal medulla surface texture: Differentiating neuromyelitis optica spectrum disorder from multiple sclerosis.
J Neuroimaging
; 32(6): 1090-1097, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36181675